{"id":70755,"date":"2026-04-02T21:54:45","date_gmt":"2026-04-03T02:54:45","guid":{"rendered":"https:\/\/news2shorts.com\/index.php\/2026\/04\/02\/trump-slaps-up-to-100-tariff-on-some-brand-name-drug-imports-in-major-america-first-push\/"},"modified":"2026-04-02T21:54:45","modified_gmt":"2026-04-03T02:54:45","slug":"trump-slaps-up-to-100-tariff-on-some-brand-name-drug-imports-in-major-america-first-push","status":"publish","type":"post","link":"https:\/\/news2shorts.com\/index.php\/2026\/04\/02\/trump-slaps-up-to-100-tariff-on-some-brand-name-drug-imports-in-major-america-first-push\/","title":{"rendered":"Trump slaps up to 100% tariff on some brand-name drug imports in major America First push"},"content":{"rendered":"<p>President <a href=\"https:\/\/www.foxnews.com\/category\/person\/donald-trump\" target=\"_blank\" rel=\"noopener\">Donald Trump<\/a> on Thursday proclaimed that certain imported patented pharmaceuticals and related ingredients could face tariffs of up to 100%, framing the move as a national security measure and intensifying his push to bring drug manufacturing back to the United States.<\/p>\n<p>The proclamation creates a tiered system for drugmakers: companies with Commerce Department-approved plans to onshore production could face a 20% tariff instead, while some firms that strike pricing and manufacturing agreements with the administration could receive zero-tariff treatment for a period.<\/p>\n<p>A senior administration official said the policy amounts to a &#8220;100% tax&#8221; on drugs produced abroad.<\/p>\n<p>Trump\u2019s proclamation states that imported pharmaceuticals and key ingredients &#8220;are being imported into the United States in such quantities and under such circumstances as to threaten to impair the national security of the United States.&#8221;<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/politics\/trumps-new-tariff-regime-barrels-back-court-following-multistate-lawsuit\" target=\"_blank\" rel=\"noopener\"><strong>TRUMP\u2019S NEW TARIFF PLAN BARRELS BACK TO COURT FOLLOWING MULTISTATE LAWSUIT<\/strong><\/a><\/p>\n<p>The move sets up a major clash over the cost and supply of brand-name medicines, as Trump argues the U.S. is overly dependent on foreign pharmaceutical manufacturing while offering lower tariffs to companies that build in America.<\/p>\n<p>According to the proclamation, about 53% of <a href=\"https:\/\/www.foxnews.com\/category\/health\/healthy-living\/medications\" target=\"_blank\" rel=\"noopener\">patented pharmaceutical products<\/a> distributed in the U.S. are produced abroad, while only 15% of patented active pharmaceutical ingredients by volume are made domestically.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/politics\/voters-react-trump-touts-signature-tariff-plan-state-union\" target=\"_blank\" rel=\"noopener\"><strong>VOTERS REACT AS TRUMP TOUTS SIGNATURE TARIFF PLAN AT STATE OF THE UNION<\/strong><\/a><\/p>\n<p>Under the framework, imports of patented pharmaceuticals listed in Annex I will face a 100% tariff, unless they qualify for lower rates.<\/p>\n<p>Companies with approved onshoring plans can instead receive a 20% tariff, though that rate rises to 100% in 2030, according to the proclamation.<\/p>\n<p>The administration is using that structure to push companies to <a href=\"https:\/\/www.foxnews.com\/category\/us\/economy\/manufacturing\" target=\"_blank\" rel=\"noopener\">shift production to the United States<\/a>, officials said.<\/p>\n<p><a href=\"https:\/\/www.foxnews.com\/politics\/trump-raises-global-tariff-15-percent\" target=\"_blank\" rel=\"noopener\"><strong>TRUMP RAISES GLOBAL TARIFF TO 15%<\/strong><\/a><\/p>\n<p>The proclamation also sets lower tariff rates for certain allies: 15% for <a href=\"https:\/\/www.foxnews.com\/category\/world\/world-regions\/japan\" target=\"_blank\" rel=\"noopener\">products from Japan<\/a>, the European Union (EU), South Korea, and Switzerland, and 10% for the United Kingdom (UK), which could fall to zero under a future agreement.<\/p>\n<p>It also creates a zero-tariff lane for companies that both onshore production and enter &#8220;Most-Favored-Nation&#8221; pricing agreements with the administration.<\/p>\n<p>Not all drugs are affected. The proclamation says <a href=\"https:\/\/www.foxnews.com\/category\/us\/crime\/drugs\" target=\"_blank\" rel=\"noopener\">generic pharmaceuticals<\/a> will not be subject to tariffs &#8220;at this time,&#8221; and U.S.-origin drugs are also excluded.<\/p>\n<p>The broader push ties into the administration\u2019s TrumpRx initiative, including the recently launched TrumpRx.gov platform, which the White House says gives Americans access to lower prices on some high-cost brand-name drugs through &#8220;Most-Favored-Nation&#8221; pricing agreements with pharmaceutical companies.<\/p>\n<p>The <a href=\"https:\/\/www.foxnews.com\/category\/world\/trade\" target=\"_blank\" rel=\"noopener\">tariffs will take effect<\/a> July 31, 2026, for some companies and Sept. 29, 2026, for others, according to the proclamation.<\/p>\n<p>Trump issued the order under Section 232 of the Trade Expansion Act of 1962, which allows the president to restrict imports deemed a national security threat.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>President Donald Trump on Thursday proclaimed that certain imported patented pharmaceuticals and related ingredients could face tariffs of up to 100%, framing the move as a national security measure and intensifying his push to bring drug manufacturing back to the United States. The proclamation creates a tiered system for drugmakers: companies with Commerce Department-approved plans &#8230; <a title=\"Trump slaps up to 100% tariff on some brand-name drug imports in major America First push\" class=\"read-more\" href=\"https:\/\/news2shorts.com\/index.php\/2026\/04\/02\/trump-slaps-up-to-100-tariff-on-some-brand-name-drug-imports-in-major-america-first-push\/\" aria-label=\"Read more about Trump slaps up to 100% tariff on some brand-name drug imports in major America First push\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_post_was_ever_published":false},"categories":[1],"tags":[],"class_list":["post-70755","post","type-post","status-publish","format-standard","hentry","category-blog"],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/70755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/comments?post=70755"}],"version-history":[{"count":0,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/posts\/70755\/revisions"}],"wp:attachment":[{"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/media?parent=70755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/categories?post=70755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/news2shorts.com\/index.php\/wp-json\/wp\/v2\/tags?post=70755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}